合佳医药 (838641.OC)

+ 收藏

财务分析(报告期)(合佳医药)

导出到EXCEL
报表日期选择
  • 常用日期查询
  • 自定义年度查询
    日期范围
    报告期
    报告类型
    显示选项
关 闭
完整财报对比
2024年中报2023年年报2023年中报2022年年报2022年中报2022年一季报
主要指标:
 营业收入(元) 410,991,106.06945,885,012.18404,586,068.28739,038,868.62392,136,414.08189,025,309.08
 营业利润(元) 20,577,210.4085,838,666.5636,039,057.6673,905,743.3437,029,006.4312,557,968.24
 利润总额(元) 19,523,835.5285,444,042.9636,050,381.9873,306,854.4935,515,489.5911,072,430.68
 净利润(元) 17,353,500.6371,551,701.0031,018,180.4762,191,954.9430,063,259.808,860,168.82
 归属于母公司股东的净利润(元) 17,353,500.6972,297,002.0631,099,671.1062,171,379.9830,254,901.169,013,023.63
盈利能力:
 销售毛利率(%) 19.7021.8120.6721.9121.4123.05
 销售净利率(%) 4.227.567.678.427.674.69
 净资产收益率(%) 1.567.433.32---
 总资产报酬率ROA(%) 1.516.332.63---
 投入资本回报率ROIC(%) 1.726.833.067.473.611.30
营运能力:
 存货周转率(次) 1.183.681.37---
 应收账款周转率(次) 1.443.541.41---
 总资产周转率(次) 0.240.610.27---
偿债能力:
 资产负债率(%) 35.6936.8335.8637.7840.3038.61
 股东权益比率(%) 64.3163.2064.1362.2059.7061.38
 已获利息倍数(倍) 3.947.7711.318.508.814.75
 流动比率 1.691.691.671.721.811.83
 速动比率 0.991.150.991.101.141.17
发展能力:
 营业收入增长率(%) 1.5827.993.176.0936.4656.82
 营业利润增长率(%) -42.9016.15-2.6766.81151.54364.01
 税后利润增长率(%) -44.2016.292.7976.50115.58238.81
 净资产增长率(%) 5.5736.8737.008.177.02-
 总资产增长率(%) 5.2734.7327.529.3322.67-

前瞻产业研究院